Medical device co Brainsway to raise $30m on Nasdaq

Brainsway will use 70-75% of the proceeds to bring its non-invasive device for neurological disorders to new markets and to mass produce the device.

Brainsway Ltd. (TASE:BRIN) has filed with the US Securities and Exchange Commission (SEC) its prospectus to raise $30 million on Nasdaq. Brainsway will use 70-75% of the proceeds to bring its non-invasive Deep TMS (transcranial magnetic stimulation) device for neurological disorders to new markets and to mass produce the device.

Brainsway plans to hold the offering by the end of May. The company will be traded under the ticker "BRIN". Maxim Group LLC and Roth Capital Ltd. are the underwriters.

Last week, Brainsway obtained EU CE Mark to use Deep TMS for the treatment of Parkinson's disease and as a supplemental treatment for patients taking antidepressants. The company is also conducting clinical trials of the device for treatment cocaine, smoking and other addictions, autism and Asperger's syndrome, and other neurological problems.

Brainsway's share price rose 1.2% by early afternoon to NIS 8.67, giving a market of NIS 406 million.

Published by Globes [online], Israel business news - www.globes-online.com - on April 12, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס